MetaCap

Who Owns Starling Oncology Stock?

NASDAQ: STLNHealth CareMedical/Nursing ServicesUSD

3.00-0.18 (-5.66%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
48.22%
Institutional holders
174
  • Institutions 48.2%
  • Insiders 15.2%
  • Public and other 36.6%

Who owns Starling Oncology stock?

Institutional investors own about 48.2% of Starling Oncology's shares, spread across 174 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 15.19% of STLN.

The largest institutional holders are Blackrock Inc. (4.66%), Deerfield Management Company, L.P (3.29%) and Vanguard Capital Management LLC (3.20%). Together, the top 10 institutions control 23.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their STLN positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of STLN

Starling Oncology top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.4.75M4.66%+7.5%
Deerfield Management Company, L.P3.36M3.29%0.0%
Vanguard Capital Management LLC3.27M3.20%-6.1%
Josh Arnold Investment Consultant, Llc2.46M2.42%0.0%
Geode Capital Management, LLC2.11M2.07%+11.1%
State Street Corporation1.98M1.94%+27.4%
Goldman Sachs Group Inc1.74M1.70%+28.4%
Wexford Capital LP1.71M1.68%0.0%
Marshall Wace LLP1.22M1.20%+257.2%
Renaissance Technologies, LLC1.18M1.16%-13.7%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of STLN

Starling Oncology top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.40M2.35%
iShares Trust-iShares Russell 2000 ETF2.01M1.97%
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund1.03M1.01%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund838.32K0.82%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund794.69K0.78%
Fidelity Select Portfolios-Select Health Care Services Portfolio627.60K0.62%
iShares Trust-iShares Russell 2000 Growth ETF555.66K0.54%
Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF486.12K0.48%
Northern Lights Fund Trust IV-Inspire Fidelis Multi Factor ETF459.34K0.45%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund439.25K0.43%

Frequently asked questions

Who is the largest shareholder of Starling Oncology?

Blackrock Inc. is the largest institutional shareholder of STLN, owning 4.66% of shares outstanding (4.75M shares) as of its latest 13F filing.

What percentage of Starling Oncology is owned by institutions?

Institutions own about 48.2% of STLN shares and 56.9% of the public float.

How much of Starling Oncology do insiders own?

Insiders, such as officers and directors, own about 15.19% of STLN shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related